If you need more lookups,
subscriptions start at $34 USD/month.
Catherine Deacon Location
Cambridge, MA, US
Catherine Deacon Work
Senior Director, Research and Development Finance, Therapeutic Area Units @ (September 2021 - Present)
Senior Director, Portfolio Strategy and Finance Operations @ (March 2017 - September 2021)
Director, R and D Controlling, Worldwide Development Programs @ (January 2015 - March 2017)
Senior Controller, Research and Development @ (July 2013 - January 2015)
Associate Director, Finance, Biotherapeutics Research @ (January 2010 - July 2013)
Manager,Finance, Oncology Business Unit @ (January 2009 - January 2010)
Senior Portfolio Liaison, Finance and Technology @ (January 2008 - January 2009)
Chief Financial Officer @ CWW (January 2006 - January 2007)
Controller @ (July 1989 - December 2004)
Catherine Deacon Education
Temple University School of Pharmacy
Masters of Science (Quality Affairs/Regulatory Assurance)
2009-2012
University of Connecticut
MBA (Finance)
University of Connecticut
Bachelors of Science (Finance)
Catherine Deacon Skills
Forecasting
Managerial Finance
Analysis
Budgets
Management
Mergers & Acquisitions
Business Development
Oncology
Leadership
Project Portfolio Management
Business Planning
Strategy
Change Management
Strategic Planning
Clinical Trials
Cross-functional Team Leadership
Human Resources
Catherine Deacon Summary
Catherine Deacon, based in Cambridge, MA, US, is currently a Senior Director, Research and Development Finance, Therapeutic Area Units at Takeda. Catherine Deacon brings experience from previous roles at TAKEDA PHARMACEUTICALS INTERNATIONAL, INC., EMD Serono, Inc. and Pfizer. Catherine Deacon holds a 2009 - 2012 Masters of Science in Quality Affairs/Regulatory Assurance @ Temple University School of Pharmacy. With a robust skill set that includes Forecasting, Managerial Finance, Analysis, Budgets, Management and more. Catherine Deacon has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Catherine Deacon?
Find contact details for 700 million professionals.